Masitinib plus FOLFIRI for second line treatment of metastatic colorectal cancer: An open label phase Ib/II trial.
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Masitinib plus FOLFIRI for second line treatment of metastatic colorectal cancer: An open label phase Ib/II trial. |
| Type de publication | Journal Article |
| Year of Publication | 2015 |
| Auteurs | Taieb J, Borg C, Lecomte T, Lepere C, Chatellier T, Smith DMichel, Dubreuil P, Mansfield C, Moussy A, Hermine O |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 33 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/jco.2015.33.15_suppl.3526 |